###begin article-title 0
###xml 91 93 91 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 94 98 94 98 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 8 10 8 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 25 28 25 28 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg</sub>
###xml 166 170 166 170 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 261 263 261 263 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 264 268 264 268 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 468 472 468 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
CD4+CD25+ regulatory T (Treg) cells develop in the thymus and can suppress T cell proliferation, modulated by Foxp3 and cytokines; however, the relevance of CD44 in Treg cell development is less clear. To address this issue, we analyzed Foxp3 expression in CD44+ Treg cells by using multiple parameters, measured the levels of the immunoregulatory cytokine interleukin (IL)-10 in various thymocyte subsets, and determined the suppressor activity in different splenic Treg cell populations.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 38 42 38 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 89 90 89 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 93 94 93 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 98 99 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 103 105 103 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 112 113 112 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 116 117 116 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 121 122 121 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 126 128 126 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 349 353 349 353 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 376 377 376 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 381 383 381 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 420 424 420 424 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 532 533 532 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 537 538 537 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 542 544 542 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 545 549 545 549 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 667 668 667 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 672 673 672 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 677 679 677 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 7 12 <span type="species:ncbi:10090">mouse</span>
Within mouse thymocytes, we detected Treg cells with two novel phenotypes, namely the CD4+CD8-CD25+CD44+ and CD4+CD8-CD25+CD44- staining features. Additional multi-parameter analyses at the single-cell and molecular levels suggested to us that CD44 expression positively correlated with Foxp3 expression in thymocytes, the production of IL-10, and Treg activity in splenic CD4+CD25+ T cells. This suppressive effect of Treg cells on T cell proliferation could be blocked by using anti-IL-10 neutralizing antibodies. In addition, CD4+CD25+CD44+ Treg cells expressed higher levels of IL-10 and were more potent in suppressing effector T cell proliferation than were CD4+CD25+CD44- cells.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 62 66 62 66 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 133 137 133 137 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 219 223 219 223 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
This study indicates the presence of two novel phenotypes of Treg cells in the thymus, the functional relevance of CD44 in defining Treg cell subsets, and the role of both IL-10 and Foxp3 in modulating the function of Treg cells.
###end p 7
###begin title 8
Reviewers
###end title 8
###begin p 9
This article was reviewed by Dr. M. Lenardo, Dr. L. Klein & G. Wirnsberger (nominated by Dr. JC Zungia-Pfluker), and Dr. E.M. Shevach.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 1 5 1 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 136 140 136 140 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 450 451 450 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 452 453 452 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 526 530 526 530 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 627 631 627 631 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 758 759 758 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 821 825 821 825 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 839 840 839 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 841 842 841 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
Treg cells are important in the control of self-reactive T cells, contributing to the maintenance of immunological self-tolerance [1]. Treg cells develop in the thymus through a process involving the recognition of self-peptides presented by major histocompatibility complex (MHC) molecules and driven by high-affinity interactions between the T cell receptor (TCR) on developing thymocytes and self peptide-MHC complexes on thymic epithelial cells [2-5]. Forkhead box P3 (Foxp3), an X-chromosome-linked factor that controls Treg cell development and function, is generally thought to also control positively the functions of Treg cells in a binary fashion, as Foxp3 expression is sufficient to specify immune-suppressive activities in conventional T cells [6]. Although Foxp3 is considered as a specific marker for the Treg cell lineage [7,8], its expression pattern during thymocyte development remains less clear.
###end p 11
###begin p 12
###xml 1 4 1 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg</sub>
###xml 53 54 53 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 170 172 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 173 175 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 359 361 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 468 472 462 466 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 600 602 594 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 655 657 649 651 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 689 691 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 755 759 749 753 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 782 790 776 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 823 827 817 821 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 874 876 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 877 879 871 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 950 954 941 945 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1070 1071 1058 1059 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1075 1076 1063 1064 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1093 1097 1081 1085 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1104 1106 1092 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
Treg-mediated suppression is cell contact dependent [9], but the immunosuppressive cytokines transforming growth factor (TGF)-beta and IL-10 also play an important role [10-12]. The collective activity of TGF-beta and IL-10 ensures a controlled inflammatory response specifically targeting pathogens without evoking excessive immunopathology to self-tissues [13]. IL-10 is a cytokine which is an essential molecule in the mechanism underlying suppression mediated by Treg cells. It has anti-inflammatory activity and indirectly suppresses cytokine production and proliferation of antigen-specific CD4+ T effector cells. IL-10 is produced by subsets of CD4+ cells with regulatory function [14]. More specifically, it has been shown that IL-10 produced by Treg cells is essential for in vivo suppression, as IL-10-deficient Treg cells can not regulate T cell induced colitis [15,16]. TGF-beta and IL-10 are potent mediators of immune suppression, and Treg cells can not only use TGF-beta and IL-10 to perform their immunosuppression function, but also to educate other CD4+CD25-cells to become Treg cells [12].
###end p 12
###begin p 13
###xml 321 323 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 549 551 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 660 662 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
The adhesion molecule CD44 (synonymous with Pgp1, HUTCH-1, or ECM-III) is the principal receptor for hyaluronic acid. Multiple functions and cellular responses have been attributed to the activation of CD44, including the induction of cell motility, activation of cell survival responses, and promotion of cell adhesion [17]. Although CD44 has a wide tissue distribution, its expression during a particular stage or in a subset of thymocyte progenitors suggests a functional involvement of CD44 in homing and thymic colonization of precursor cells [18]. Although differential expression levels of CD44 among different subsets of thymocytes have been reported [19], its biological relevance in T cell differentiation is unclear.
###end p 13
###begin p 14
###xml 175 184 175 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 359 360 359 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 364 365 364 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 369 371 369 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 372 376 372 376 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 494 495 494 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 499 500 499 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 504 506 504 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 577 581 577 581 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 611 615 611 615 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 706 707 706 707 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 711 712 711 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 716 721 716 721 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 294 299 <span type="species:ncbi:10090">mouse</span>
In this study, we used naive C57BL/6 mice and performed six-color flow cytometry and real-time reverse transcriptase (RT)-polymerase chain reaction (PCR) analyses, as well as in vitro T cell suppression assays. We present herein the following key findings: 1) the surface expression of CD44 in mouse thymocytes positively correlated with that of Foxp3; 2) CD4+CD25+CD44+ Treg cells expressed higher levels of IL-10 and were more potent in suppressing effector T cell proliferation than were CD4+CD25+CD44- cells; and 3) blocking IL-10 aborogated suppressive mechanisms of CD4 Treg cells. Our data suggest that Treg cells could be further divided into three subsets based on CD44 expression levels, with CD4+CD25+CD44high cells displaying the highest levels of IL-10 production and having regulatory functions.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 16
###begin p 17
###xml 15 19 <span type="species:ncbi:10090">mice</span>
Female C57BL/6 mice (Taconic Farms, Germantown, NY) were maintained under specific pathogen-free conditions, and used for experimentation at 4 to 6 weeks of age, according to protocols approved by the UTMB Institutional Animal Care and Use Committee and NIH guidelines.
###end p 17
###begin title 18
Flow cytometric analysis
###end title 18
###begin p 19
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 119 123 <span type="species:ncbi:9913">calf</span>
###xml 170 175 <span type="species:ncbi:10090">mouse</span>
###xml 219 224 <span type="species:ncbi:10090">mouse</span>
###xml 804 807 <span type="species:ncbi:10116">rat</span>
Thymocytes and splenocytes were obtained from naive mice and suspended in phosphate-buffered saline (PBS) and 1% fetal calf serum (FCS). To avert non-specific binding to mouse Fcgamma receptors, cells were blocked with mouse CD16/CD32 mAb (0.25 mug/100 mul) (BD Biosciences, Franklin Lakes, NJ) for 15 min. After washing, cells were stained for the expression of CD4 (PE-Cy7, clone RM 4-5), CD8alpha (FITC, clone 53-6.7), CD44 (PE, clone 1M7), CD25 (APC-Alexa Fluor755, clone PC-61.5), or TCR-beta (PerCp, clone H57-597) at 4degreesC for 60 min. In some cases, the surface-stained cells were fixed/permeabilized with a Cytofix/Cytoperm kit (BD Biosciences) and then stained with Foxp3 (PE-Cy5, clone FJK-16s) or IL-10 (PerCP, clone JESS-16E3) at 4degreesC for 45 min. The corresponding isotype controls (rat IgG1, IgG2a, and IgG2b) were purchased from eBioscience (San Diego, CA) and BD Bioscience, respectively. Cells were analyzed using a FACScan (BD Biosciences) and BD FACSDiva software (BD Biosciences).
###end p 19
###begin title 20
###xml 16 18 16 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Isolation of CD4+ T subsets
###end title 20
###begin p 21
###xml 215 216 215 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8</sup>
###xml 285 287 279 281 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 531 533 519 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 596 597 584 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 601 602 589 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 606 607 594 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 612 613 600 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 617 618 605 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 622 623 610 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 628 629 616 617 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 633 634 621 622 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 638 642 626 630 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 647 648 635 636 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 652 653 640 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 657 660 645 648 <sup xmlns:xlink="http://www.w3.org/1999/xlink">med</sup>
###xml 669 670 657 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 674 675 662 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 679 683 667 671 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Splenocytes were collected from C57BL/6 mice, treated with RBC lysis buffer (Sigma, St. Louis, MO), and T cells were enriched by passage through nylon-wool columns and subsequently purified. Briefly, splenocytes (108) were incubated in the column at 37degreesC in the presence of 5% CO2 for 1 h before eluting the cells with RPMI medium. Cells were then stained for the surface expression of CD4, CD8, CD44, and CD25 by incubating with the appropriate antibodies at 4degreesC for 60 min. After washing, the following subsets of CD4+ T cells were isolated by using a FACSAria (BD Biosciences): CD4+CD25+CD44+, CD4+CD25+CD44-, CD4+CD25+CD44high, CD4+CD25+CD44med, and CD4+CD25+CD44low cells. Purified T cell subsets were immediately used for subsequent analyses.
###end p 21
###begin title 22
RT-PCR and real-time RT-PCR
###end title 22
###begin p 23
###xml 224 228 223 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq </italic>
###xml 367 368 365 366 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
Total RNA was extracted from purified T cell subsets. The first-strand cDNA was synthesized from 2 mug of RNA using reverse transcriptase (SuperScript III, Invitrogen). An aliquot of first-strand cDNA was amplified by Ampli-Taq (Perkin-Elmer Cetus, Norwalk, CT) in a total volume of 50 mul reaction buffer consisting of 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 0.001% gelatin, and 0.2 mM deoxynucleoside triphosphate. The primers for RT-PCR were: IL-10 forward 5'-CAGACTCTTAAACACCGAGCCG-3', reverse 5'-GACTTAGCAAGACACGATGCGA-3'; and beta-actin forward 5'-TGGAATCCTGTGGCATCCATGAAAC-3', reverse 5'-TAAAACGCAGCTCAGTAACAGTCCG-3'. The PCR reaction included one cycle of initial amplification (at 94degreesC for 5 min, 56degreesC for 3 min, 72degreesC for 2 min), followed by 22 to 32 cycles at 94degreesC for 1 min, annealing at 56degreesC for 1 min, and extension at 72degreesC for 0.5 min. The final extension reaction was prolonged to 10 min at 72degreesC. After amplification, PCR products were separated by electrophoresis through 1-2% agarose gels.
###end p 23
###begin p 24
###xml 369 373 351 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 802 804 758 760 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T </sub>
###xml 825 829 781 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">via </italic>
###xml 882 884 838 840 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T </sub>
###xml 896 897 844 845 <sub xmlns:xlink="http://www.w3.org/1999/xlink">T</sub>
###xml 985 998 933 938 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-&#916;&#916;CT</sup>
Quantitative RT-PCR was performed at the Real-Time PCR Core Facility, Sealy Center for Cancer Cell Biology, UTMB. We used Applied Biosystems (Foster City, CA) assay-by-design and assay-on-demand 20x assay mixes of primers and TaqMan MGB probes (FAMtrade mark dye-labeled) for our target genes (IL-10) and a pre-developed 18S rRNA (VICtrade mark-dye labled probe) TaqMan(R) assay reagent for an endogenous control. Real-time RT-PCR was performed with 40 ng cDNA, using a universal PCR master mix reagent kit (Applied Biosystems) and the following cycling parameters: Uracil-N-glycosylase (UNG) activation at 50degreesC for 2 min, AmpliTaq activation at 95degreesC for 10 min, denaturation at 95degreesC for 15 sec and annealing/extension at 60degreesC for 1 min (repeat 40 times) on ABI7000. Duplicate CT values were analyzed via an in Microsoft Excel program using the comparative CT (DeltaDeltaCT) method, as described by the manufacturer (Applied Biosystems). The amount of target (2-DeltaDeltaCT) was obtained and normalized to the endogenous reference (18s) and relative to a calibrator (one of the experimental samples).
###end p 24
###begin title 25
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
In vitro T cell suppression assay
###end title 25
###begin p 26
###xml 83 85 83 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8 </sup>
###xml 164 166 158 160 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 370 371 363 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 389 393 382 386 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 414 417 407 410 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg</sub>
###xml 543 544 535 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
Splenic T cells were prepared by passing splenocytes through nylon-wool columns (108 splenocytes were incubated in the column at 37degreesC in the presence of 5% CO2 for 1 h before eluting the cells with RPMI medium). Effector T cells were pre-cultured with Concanavalin A (Con A, 20 mug/ml) for 2 h, washed, and then seeded in 96-well U-bottom microtiter plates (2 x 105/well), to which Treg cells were added at Treg-to-effector cells in a ratio of 1:2. After cultivation in the presence of Con A (2 mug/ml) for 72 h, cells were pulsed with [3H]-thymidine for the last 10 h, and incorporation of radioactivity was measured by liquid scintillation counting in triplicate. Data were expressed as the arithmetic means +/- standard deviation (S.D.).
###end p 26
###begin p 27
###xml 81 83 81 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 87 89 87 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 96 98 96 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 102 104 102 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 108 110 108 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 117 118 117 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 122 124 122 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 128 129 128 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 137 141 137 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">via </italic>
###xml 214 218 214 218 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 567 569 560 562 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 617 618 610 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 412 415 <span type="species:ncbi:10116">rat</span>
To assess the involvement of IL-10 in reversing T cell suppression, we sorted CD4+ CD25- and CD4+ CD25+ CD44+ (or CD4+CD25+ CD44-) cells via FACS. T cells (in RPMI medium) were incubated alone or co-cultured with Treg cells at a 2:1 ratio with 1 mug/ml plate-bound anti-CD3 (145.2C11, BD Bioscience) in 96-well U-bottom plates. In some cases, blocking anti IL-10 antibodies (1B1.3a, 100 ng/ml, BD Bioscience) or rat IgG1 isotype control (R3-34, 100 ng/ml, BD Bioscience) were added, and the above mixture of cells were incubated at 37degreesC in the presence of 5% CO2 for 72 h. Subsequently, cells were pulsed with [3H]-thymidine for the last 10 h, and incorporation of radioactivity was measured by liquid scintillation counting in triplicate. Data were expressed as the arithmetic means +/- S.D.
###end p 27
###begin title 28
Statistical analysis
###end title 28
###begin p 29
###xml 124 125 124 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 301 303 301 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 315 317 315 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 330 332 330 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
At least three independent experiments were performed, and the difference between two groups was determined using Student's t-test. One- or two-way ANOVA was used for multiple group comparisons (GraphPad Software v 4.0, San Diego, CA). Statistically significant values were referred to as follows: *, p < 0.05; **, p < 0.01; ***, p < 0.001.
###end p 29
###begin title 30
Results
###end title 30
###begin title 31
###xml 16 17 16 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 25 26 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 30 32 30 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 39 40 39 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 43 44 43 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 48 49 48 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 53 55 53 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Detection of CD4+CD8-CD25+CD44- and CD4+CD8-CD25+CD44+ T cells in the thymus
###end title 31
###begin p 32
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 8 10 8 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 172 176 172 176 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 605 606 605 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 609 610 609 610 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 614 615 614 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 619 621 619 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 651 652 651 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 655 656 655 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 660 661 660 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 665 667 665 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 711 712 711 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 715 716 715 716 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 720 721 720 721 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 725 727 725 727 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 734 735 734 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 738 739 738 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 743 744 743 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 748 750 748 750 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 856 858 856 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 917 918 917 918 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 921 922 921 922 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 926 927 926 927 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 931 933 931 933 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 953 954 953 954 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 957 958 957 958 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 962 963 962 963 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 967 969 967 969 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 983 985 983 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
CD4+CD25+ cells are members of a unique lineage of T cells that are selected during the process of T cell development in the thymus; however, the location and sequence of Treg cell development remain unclear [20-22]. To address this issue, we first examined the profile of thymocytes in naive mice using multi-color flow cytometry for the simultaneous detection of CD4, CD8, CD25, and CD44 cells. As shwon in Figure 1A, live thymocytes were gated as P1, and these thymocytes were subsequently divided into four populations based on CD44 and CD8 expression (identified by quadrants Q1-Q4), yielding the CD4+CD8-CD25+CD44- population from Q3 and the CD4+CD8-CD25+CD44+ population from Q4. These populations of CD4+CD8-CD25+CD44- and CD4+CD8-CD25+CD44+ single positive (SP) cells were comprised of only 0.4% and 0.8% of total thymocytes, respectively (Figure 1B). Furthermore, Foxp3 expression was detacted in 63% of CD4+CD8-CD25+CD44+ cells and 26% of CD4+CD8-CD25+CD44- cells (Figure 1C). These staining and gating approaches allowed us to detect 16 distinct subsets of cells.
###end p 32
###begin p 33
###xml 16 18 16 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 21 23 21 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 27 29 27 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 43 45 43 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 48 50 48 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 54 56 54 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 60 62 60 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 63 67 63 67 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 0 86 0 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Detection of CD4<sup>+ </sup>CD8<sup>- </sup>CD25<sup>+ </sup>CD44<sup>+ </sup>and CD4 <sup>+ </sup>CD8<sup>- </sup>CD25<sup>+ </sup>CD44<sup>- </sup>T<sub>reg </sub>cells in the thymus</bold>
###xml 88 92 88 92 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 341 345 341 345 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 382 383 382 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 386 387 386 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 391 392 391 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 396 398 396 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 405 406 405 406 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 409 410 409 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 414 415 414 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 419 421 419 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 441 445 441 445 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 468 469 468 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 472 473 472 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 477 478 477 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 482 484 482 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 491 492 491 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 495 496 495 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 500 501 500 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 505 507 505 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
Detection of CD4+ CD8- CD25+ CD44+ and CD4 + CD8- CD25+ CD44- Treg cells in the thymus. (A) Cell gating strategy and staining patterns. Thymocytes were obtained from naive C57BL/6 mice and stained with specific antibodies against CD4 (Cy7-PE), CD8 (FITC), CD44 (PE), and CD25 (APC-Alexa Fluor755). Cells in P1 were gated as live thymocytes. (B) Based on CD44 and CD8 expression, CD4+CD8-CD25+CD44+ and CD4+CD8-CD25+CD44- cells were defined. (C) Foxp3 expression in CD4+CD8-CD25+CD44+ and CD4+CD8-CD25+CD44- cells. The data are shown as the percentage of total, live thymocytes (population P1) in each cell subset, and are presented as mean +/- S.D. from four independent experiments.
###end p 33
###begin title 34
###xml 35 39 32 36 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
TCR-beta expression in subsets of Treg cells in the thymus
###end title 34
###begin p 35
###xml 111 113 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 114 116 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 203 205 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 270 271 264 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 341 342 335 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 345 347 339 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 357 358 351 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 361 363 355 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 377 378 371 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 381 383 375 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 602 603 593 594 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 606 607 597 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 611 612 602 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 616 618 607 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 665 667 653 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 685 686 673 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 689 690 677 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 694 695 682 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 699 701 687 689 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 715 717 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 791 792 779 780 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 796 798 784 786 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 822 823 810 811 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 826 827 814 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 831 832 819 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 836 838 824 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 855 856 843 844 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 859 860 847 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 864 865 852 853 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 869 872 857 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 877 878 865 866 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 881 882 869 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 886 887 874 875 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 891 894 879 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink">med</sup>
###xml 903 904 891 892 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 907 908 895 896 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 912 913 900 901 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 917 922 905 910 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 936 938 924 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 1032 1034 1017 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 1046 1047 1031 1032 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1050 1051 1035 1036 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1055 1056 1040 1041 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1071 1076 1056 1061 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 1165 1169 1147 1151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 1347 1348 1323 1324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1352 1354 1328 1330 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1358 1363 1334 1339 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
Since a productive TCR-beta gene rearrangement is a critical event in thymocyte development and proliferation [23,24], we then examined TCR-beta expression in different subsets of thymocytes. For Figure 2A, total live thymocytes (P1) were gated, as described for Figure 1. Based on expression of CD4 and CD8, we defined subpopulations of CD4-CD8- as P4, CD4+CD8+ as P3, and CD4+CD8- cells as P5, respectively. Each of these subpopulations was further analyzed for expression of CD25 and CD44. Finally, for each of the resulting nine subpopulations, we measured TCR-beta expression. We observed that CD4+CD8-CD25+CD44+ cells contained a higher percentage of TCR-beta+ cells than did CD4+CD8-CD25+CD44- cells (Figure 2B). To further define the role of CD44 expression in the development of CD4+CD25+ cells, we subdivided CD4+CD8-CD25+CD44+ SP cells into CD4+CD8-CD25+CD44low, CD4+CD8-CD25+CD44med, and CD4+CD8-CD25+CD44high cells (Figure 2A). We then analyzed the percentage of TCR-beta-expressing cells in each subpopulation (Figure 2C). Among CD4+CD8-CD25+cells, the CD44high subpopulation expressed TCR-beta at the highest frequency and intensity, whereas the CD44low subpopulation displayed the lowest expression levels of TCR-beta. Thus, the surface expression of CD44 was positively correlated with TCR-beta expression, suggesting that the CD4+CD25+ CD44high cells represent a more mature subset of T cells.
###end p 35
###begin p 36
###xml 26 28 23 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 31 33 28 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 37 39 34 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 43 45 40 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 47 51 44 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 0 72 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TCR-&#946; expression on CD4<sup>+ </sup>CD8<sup>- </sup>CD25<sup>+ </sup>CD44<sup>+ </sup>T <sub>reg </sub>cells in mouse thymus</bold>
###xml 266 270 260 264 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 273 274 267 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 277 279 271 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 288 289 282 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 292 294 286 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 307 308 301 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 311 313 305 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 447 448 441 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 452 454 446 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 462 463 456 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 467 469 461 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 501 502 495 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 506 508 500 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 516 517 510 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 521 523 515 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 579 580 573 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 583 585 577 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 617 618 611 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 622 625 616 619 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 631 632 625 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 636 639 630 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink">med</sup>
###xml 649 650 643 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 654 659 648 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 699 702 693 696 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B) </bold>
###xml 742 743 733 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 746 748 737 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 781 785 770 774 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 828 829 814 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 833 834 819 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 838 841 824 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low</sup>
###xml 846 847 832 833 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 851 852 837 838 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 856 859 842 845 <sup xmlns:xlink="http://www.w3.org/1999/xlink">med</sup>
###xml 868 869 854 855 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 873 874 859 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 878 883 864 869 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 951 953 937 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 967 969 953 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
TCR-beta expression on CD4+ CD8- CD25+ CD44+ T reg cells in mouse thymus. Thymocytes were collected from naive mice, stained with antibodies against CD4 (PE-Cy7), CD8 (FITC), CD44 (PE), CD25 (APC-Alexa Fluor755), and TCR-beta(PerCp), and analyzed by flow cytometry. (A) CD4-CD8- (P4), CD4+CD8+ (P3), and CD4+CD8- cells (P5) were gated from total, live thymocytes (P1). Cells from each of the quadrants (designated as P3-P5) were subgated into CD25+CD44- and CD25+CD44+ (In Figure 2A, - and + mean CD25+CD44- and CD25+CD44+ cells [analysis described in panel B]). In addition, CD4+CD8- SP cells were subgated into CD25+CD44low, CD25+CD44med, and CD25+CD44high cells (analysis described in panel C). (B) The percentages of TCR-beta cells in CD4+CD8- SP cells (mean +/- S.D., n = 3). (C) The percentages of TCR-beta cells among CD4+CD25+CD44low, CD4+CD25+CD44med, and CD4+CD25+CD44high cells. Statistical significance in panels B and C is indicated by * p < 0.05 and ** p < 0.01.
###end p 36
###begin title 37
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
Foxp3 and CD44 expression in mouse thymocytes and splenocytes
###end title 37
###begin p 38
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 375 376 375 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 380 381 380 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 385 387 385 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 427 428 427 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 432 433 432 433 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 437 439 437 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 459 461 459 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 564 565 564 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 569 571 569 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 614 615 614 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 619 620 619 620 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 624 629 624 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 650 651 650 651 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 655 656 655 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 660 664 660 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink">med </sup>
###xml 690 691 690 691 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 695 696 695 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 700 704 700 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 718 720 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 755 756 755 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 785 786 785 786 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 790 791 790 791 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 828 829 828 829 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 833 835 833 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 856 858 856 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 873 875 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 892 893 892 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 897 902 897 902 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 980 982 980 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 1000 1001 1000 1001 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1006 1007 1006 1007 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1058 1059 1058 1059 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1064 1066 1064 1066 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1095 1097 1095 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3E</xref>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
To test whether there are functional differences between different subsets of CD44-expressing cells, we examined the expression profile of Foxp3. Thymocytes derived from naive mice were stained with antibodies against CD4, CD8, CD25, CD44, and Foxp3 (Figure 3). In three independently performed experiments, we consistently found that a significantly higher proportion of CD4+CD25+CD44+ cells expressed Foxp3 as compared to CD4+CD25+CD44- cells (63% vs. 26%, p < 0.01, Figure 3A). We also observed a positive correlation between CD44 and Foxp3 expression among CD4+CD25+ cells. Foxp3 was detected in 87% of the CD4+CD25+CD44high cells, 41% of the CD4+CD25+CD44med cells, and 5.9% of the CD4+CD25+CD44low cells (Figure 3B). Consistent with another report [2], a higher proportion of CD4+CD25+cells expressed Foxp3 compared to CD4+CD25- cells (52% vs. 3.2%, p < 0.01, Figure 3C). Again, the CD4+CD44high population contained the highest proportion of Foxp3-expressing cells (Figure 3D). Most of the CD4+Foxp3+cells also expressed CD44 (78%), whereas 31% of CD4+Foxp3- cells expressed CD44 (Figure 3E). Thus, we found a positive correlation between Foxp3 and CD44 expression, suggesting that CD44 may be an additional marker for the maturation of regulatory thymocytes.
###end p 38
###begin p 39
###xml 0 51 0 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Foxp3 expression in different subsets of thymocytes</bold>
###xml 188 189 188 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 192 194 192 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 201 202 201 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 205 207 205 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 214 215 214 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 218 220 218 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 231 232 231 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 235 237 235 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 287 291 287 291 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 318 319 318 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 323 325 323 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 378 382 378 382 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 409 410 409 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 414 416 414 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 474 478 474 478 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 505 507 505 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 560 564 560 564 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D) </bold>
###xml 591 593 591 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 651 655 651 655 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(E) </bold>
###xml 681 683 681 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 836 838 834 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 849 851 847 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 863 865 861 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
Foxp3 expression in different subsets of thymocytes. Thymocytes were stained with antibodies against CD4 (PE-Cy7), CD8 (FITC), CD44 (PE), CD25 (APC-Alexa Fluor755), and Foxp3 (PE-Cy5). CD4-CD8- DN, CD4+CD8- SP, CD4-CD8+ SP, and CD4+CD8+ DP thymocytes were gated for subsequent analyses. (A) Foxp3 expression (%) in CD4+CD25+ cells that was either positive or negative for CD44. (B) Foxp3 expression (%) in CD4+CD25+ cells that expressed high, medium, or low levels of CD44. (C) Foxp3 expression (%) in CD4+ cells that was either positive or negative for CD25. (D) Foxp3 expression (%) in CD4+ cells that expressed high, medium, or low levels of CD44. (E) CD44 expression (%) in CD4+ cells that was either positive or negative for Foxp3. Panels A to E show representative results with mean +/- S.D. from three independent experiments (* p < 0.05, ** p < 0.01, *** p < 0.001).
###end p 39
###begin p 40
###xml 162 163 162 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 167 169 167 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 173 175 173 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 213 214 213 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 218 219 218 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 223 225 223 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 334 335 334 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 339 341 339 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 384 385 384 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 389 390 389 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 394 399 394 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 420 421 420 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 425 426 425 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 430 434 430 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink">med </sup>
###xml 459 460 459 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 464 465 464 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 469 473 469 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
To validate these findings, we also stained splenocytes with antibodies against CD4, CD8, CD25, CD44, and Foxp3. We found a significantly higher proportion of CD4+CD25+ CD44+ cells expressed Foxp3 than that of CD4+CD25+CD44- cells (61% vs. 25%, Figure 4A), suggesting a positive correlation between CD44 and Foxp3 expression among CD4+CD25+ cells. Foxp3 was detected in 72% of the CD4+CD25+CD44high cells, 42% of the CD4+CD25+CD44med cells, and 13% of the CD4+CD25+CD44low cells (Figure 4B).
###end p 40
###begin p 41
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Foxp3 expression in different subsets of splenocytes</bold>
###xml 214 218 214 218 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 245 246 245 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 250 252 250 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 305 309 305 309 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 336 337 336 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 341 343 341 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 492 494 490 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 506 508 504 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
Foxp3 expression in different subsets of splenocytes. Splenocytes were stained with antibodies against CD4 (PE-Cy7), CD8 (FITC), CD44 (PE), CD25 (APC-Alexa Fluor755), Foxp3 (PE-Cy5) and analyzed by flow cytometry. (A) Foxp3 expression (%) in CD4+CD25+ cells that was either positive or negative for CD44. (B) Foxp3 expression (%) in CD4+CD25+ cells that expressed high, medium, or low levels of CD44. Shown are representative results with mean +/- S.D. from three independent experiments (** p < 0.01, *** p < 0.001).
###end p 41
###begin title 42
###xml 26 30 26 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
Functional assessment of Treg cell subsets in the thymus and spleen
###end title 42
###begin p 43
###xml 22 23 22 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 27 28 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 32 34 32 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 46 47 46 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 51 53 51 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 126 127 126 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 131 132 131 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 136 138 136 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 145 146 145 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 150 151 150 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 155 157 155 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 333 334 333 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 347 351 347 351 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 457 459 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 473 474 472 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 478 479 477 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 483 485 482 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 492 493 491 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 497 498 496 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 502 504 501 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 563 564 562 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 568 569 567 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 573 575 572 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 637 638 636 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 642 643 641 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 647 649 646 648 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 706 710 705 709 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 717 719 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 720 722 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 737 741 736 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">via </italic>
###xml 788 789 787 788 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 793 794 792 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 798 800 797 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 807 808 806 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 812 813 811 812 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 817 819 816 818 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 878 879 877 878 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 883 884 882 883 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 888 890 887 889 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 907 908 906 907 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 912 913 911 912 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 917 919 916 918 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 985 987 984 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 992 994 991 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 1084 1086 1083 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 1129 1130 1128 1129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1134 1135 1133 1134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1139 1143 1138 1142 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 1148 1149 1147 1148 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1153 1154 1152 1153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1158 1161 1157 1160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">med</sup>
###xml 1170 1171 1169 1170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1175 1176 1174 1175 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1180 1184 1179 1183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 1285 1287 1284 1286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5E</xref>
###xml 1292 1293 1291 1292 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1297 1299 1296 1298 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1303 1308 1302 1307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 1309 1313 1308 1312 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1371 1372 1370 1371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1376 1377 1375 1376 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1381 1385 1380 1384 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 1430 1434 1429 1433 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1522 1526 1521 1525 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1546 1547 1545 1546 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1550 1551 1549 1550 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1555 1556 1554 1555 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1560 1561 1559 1560 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1566 1567 1565 1566 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1570 1571 1569 1570 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1575 1576 1574 1575 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1580 1581 1579 1580 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1586 1587 1585 1586 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1590 1591 1589 1590 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1595 1596 1594 1595 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1600 1601 1599 1600 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1610 1611 1609 1610 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1614 1615 1613 1614 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1619 1620 1618 1619 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1624 1626 1623 1625 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1725 1727 1724 1726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5F</xref>
###xml 1753 1755 1752 1754 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1773 1774 1772 1773 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1778 1780 1777 1779 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1861 1865 1860 1864 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1992 1993 1991 1992 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1997 1999 1996 1998 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 2007 2008 2006 2007 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 2012 2014 2011 2013 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2030 2031 2029 2030 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2035 2036 2034 2035 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2040 2042 2039 2041 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 2049 2050 2048 2049 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2054 2055 2053 2054 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 2059 2061 2058 2060 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 2142 2146 2141 2145 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
To examine whether CD4+CD25+CD44+ and CD4+CD25+CD44- cells differ in their ability to suppress effector T cells, we sorted CD4+CD25+CD44+ and CD4+CD25+CD44- cells from the spleen by FACS. Isolated cell populations were then co-cultured with naive T cells pre-activated with Con A for 2 h. After co-culture of effector T cells (2 x 105/well) with Treg cells in the presence of Con A (2 mug/ml) for 72 h, T cell proliferation was measured. As shown in Figure 5A, although CD4+CD25+CD44+ and CD4+CD25+CD44- cells were capable of suppressing T cell proliferation, CD4+CD25+CD44+ cells were significantly more potent suppressors than were CD4+CD25+CD44- cells. Because the expression of IL-10 is a hallmark of Treg cells [12,16], we examined via RT-PCR the levels of IL-10 mRNA in purified CD4+CD25+CD44+ and CD4+CD25+CD44- cells. The levels of IL-10 were 2 to 2.4-fold higher in CD4+CD25+CD44+ cells than in CD4+CD25+CD44- cells, as determined by densitometry scanning of the gels (Figure 5B and 5C) and the data were pooled from three independent experiments and shown in a plot (Figure 5D). To confirm these findings, we sorted CD4+CD25+CD44high, CD4+CD25+CD44med, and CD4+CD25+CD44low cells from the spleens and measured the levels of IL-10 mRNA by real-time RT-PCR. As shown in Figure 5E, CD4+CD25+ CD44high Treg cells expressed 5-fold higher levels of IL-10 than did CD4+CD25+CD44low cells. Thus, the CD44 expression levels and Treg function were positively correlated. To further examine the intrathymic development of Treg cells, we sorted CD4+CD8-CD25+CD44+, CD4+CD8-CD25+CD44-, CD4+CD8-CD25-CD44+, and CD4+CD8-CD25-CD44- cells from the thymus and measured the levels of IL-10 by real-time RT-PCR. It was noted in Figure 5F that among these four CD4+ cell subsets, CD25+CD44+ cells expressed the highest levels of IL-10 mRNA, and therefore represented the Treg cell population with the highest suppressive activity. There were no major differences with regard to IL-10 expression for CD25+CD44- and CD25-CD44+ cells. Thus, CD4+CD25+CD44+ and CD4+CD25+CD44- cells both displayed regulatory functions, but the former displayed more potent Treg activity than the latter.
###end p 43
###begin p 44
###xml 26 28 26 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 32 34 32 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 38 40 38 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 47 49 47 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 53 55 53 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 59 61 59 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 0 72 0 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Regulatory function of CD4<sup>+ </sup>CD25<sup>+ </sup>CD44<sup>+ </sup>and CD4<sup>+ </sup>CD25<sup>+ </sup>CD44<sup>- </sup>splenocytes</bold>
###xml 74 78 74 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 81 82 81 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 86 87 86 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 91 93 91 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 100 101 100 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 105 106 105 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 110 111 110 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 190 191 190 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 241 242 241 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 339 340 339 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 460 464 458 462 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 505 506 503 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 510 511 508 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 515 517 513 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 524 525 522 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 529 530 527 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 534 536 532 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 583 587 581 585 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 781 785 776 780 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D) </bold>
###xml 864 868 859 863 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(E) </bold>
###xml 924 926 919 921 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 947 948 942 943 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 952 953 947 948 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 957 961 952 956 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 966 967 961 962 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 971 972 966 967 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 976 980 971 975 <sup xmlns:xlink="http://www.w3.org/1999/xlink">med </sup>
###xml 987 988 982 983 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 992 993 987 988 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 997 1001 992 996 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 1051 1055 1046 1050 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(F) </bold>
###xml 1058 1059 1053 1054 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1062 1063 1057 1058 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1067 1068 1062 1063 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1072 1073 1067 1068 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1078 1079 1073 1074 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1082 1083 1077 1078 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1087 1088 1082 1083 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1092 1093 1087 1088 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1098 1099 1093 1094 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1102 1103 1097 1098 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1107 1108 1102 1103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1112 1113 1107 1108 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1122 1123 1117 1118 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1126 1127 1121 1122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1131 1132 1126 1127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1136 1138 1131 1133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1404 1406 1396 1398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 1417 1419 1409 1411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 1431 1433 1423 1425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
###xml 1045 1049 <span type="species:ncbi:10090">mice</span>
###xml 1181 1185 <span type="species:ncbi:10090">mice</span>
Regulatory function of CD4+ CD25+ CD44+ and CD4+ CD25+ CD44- splenocytes. (A) CD4+CD25+CD44+ and CD4+CD25+CD44-cells were sorted from the splenocytes of C57BL/6 mice, and these cells (1 x 105/well) were co-cultured with naive T cells (2 x 105/well) in the presence of Con A for 72 h. T cell proliferation was measured by incorporation of [3H]-thymidine. Data are presented as counts per min, and shown are the mean +/- S.D. from three independent experiments. (B) Total RNA was extracted from purified CD4+CD25+CD44+ and CD4+CD25+CD44- cells for RT-PCR analysis of IL-10 expression. (C) The integrated density values (IDV) for the IL-10 transcripts were quantitated and normalized to those of beta-actin. Shown are representative results from one of three independent experiments. (D) The data were pooled from three independent experiments and shown in the plot. (E) The levels of IL-10 mRNA among different subsets of CD44+ expressing cells. CD4+CD25+CD44high, CD4+CD25+CD44med and CD4+CD25+CD44low cells were sorted from the spleens of naive mice. (F) CD4+CD8-CD25+CD44+, CD4+CD8-CD25+CD44-, CD4+CD8-CD25-CD44+, and CD4+CD8-CD25+CD44- cells were sorted from the thymus of naive mice. Total RNA was isolated for measuring IL-10 mRNA by real-time RT-PCR. Data are presented as fold-induction relative to the levels of beta-actin. Shown are representative results one of three independent experiments.(* p < 0.05, ** p < 0.01, *** p < 0.001).
###end p 44
###begin title 45
###xml 6 10 6 10 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
CD44 Treg cells produce IL-10 that suppresses T cell proliferation
###end title 45
###begin p 46
###xml 45 47 45 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 288 289 288 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 293 294 293 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 298 300 298 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 403 404 403 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 408 409 408 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 413 415 413 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 481 483 481 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 526 528 526 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 540 541 540 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 545 546 545 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 550 552 550 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 557 559 557 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 672 673 672 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 677 678 677 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 682 684 682 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 689 691 689 691 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 732 734 732 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 739 741 739 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
To determine that IL-10 was produced by Foxp3+ T cells but not by other cells, we isolated thymocytes and splenocytes from naive mice and stained them with antibodies against CD4, CD8, CD25, CD44, IL-10. As shown in Figure 6A and 6C, we found that a significantly higher proportion of CD4+CD25+CD44+ cells produced IL-10 in the splenocytes and thymocytes (6.0% and 3.2%, respectively) as compared to CD4+CD25+CD44- cells in splenocytes and thymocytes (0.6% and 0.4%, respectively, p < 0.01). Likewise, the percentages of IL-10+ cells in CD4+CD25+CD44+ Foxp3+ T cells derived from the spleen and thymus (27% and 31%, respectively) were signficnatly higher than those in CD4+CD25+CD44- Foxp3+ cells (18% and 15%, respectively, Figure 6B and 6D).
###end p 46
###begin p 47
###xml 31 35 31 35 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 0 70 0 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Intracelluler IL-10 levels in T<sub>reg </sub>cells of thymocytes and splenocytes</bold>
###xml 84 94 84 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A and B) </bold>
###xml 109 119 109 119 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C and D) </bold>
###xml 311 321 311 321 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A and C) </bold>
###xml 345 347 345 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 359 360 359 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 364 365 364 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 369 371 369 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 378 379 378 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 383 384 383 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 388 390 388 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 397 407 397 407 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B and D) </bold>
###xml 431 433 431 433 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 445 446 445 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 450 451 450 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 455 456 455 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 461 463 461 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 470 471 470 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 475 476 475 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 480 482 480 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 487 489 487 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
Intracelluler IL-10 levels in Treg cells of thymocytes and splenocytes. Splenocytes (A and B) and thymocytes (C and D) were obtained from naive C57BL/6 mice, stained with mAbs against CD4 (PE-Cy7), CD8 (FITC), CD44 (PE), CD25 (APC-Alexa Fluor755), Foxp3 (APC) and IL-10 (PerCP), and analyzed by flow cytometry. (A and C) The percentages of IL-10+ cells in CD4+CD25+CD44- and CD4+CD25+CD44+ cells. (B and D) The percentages of IL-10+ cells in CD4+CD25+CD44-FoxP3+ and CD4+CD25+CD44+ FoxP3+ cells. Shown are representative results from one of four independent experiments. Data in B and D are presented as mean +/- S.D.
###end p 47
###begin p 48
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">via </italic>
###xml 123 127 123 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">via </italic>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 251 255 251 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 265 266 265 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 270 272 270 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 279 280 279 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 284 285 284 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 289 290 289 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 297 298 297 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 302 303 302 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 307 308 307 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 384 385 384 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 389 390 389 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 395 397 395 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 401 402 401 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 692 694 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 725 729 725 729 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 518 521 <span type="species:ncbi:10116">rat</span>
IL-10 plays a pivotal role in maintaining homestasis via direct or indirect control of activation, proliferation, but also via its effects on regulatory T cells [25]. To further confirm whether blocking IL-10 aborogated suppressive mechanisms of CD4 Treg cells, CD4+CD25- and CD4+CD25+CD44+(or CD4+CD25+CD44-) cells were sorted by FACSAria and were incubated alone or co-cultured (CD4+CD25-: CD4+ CD25+) at a 2:1 ratio in the presence of anti-CD3 antibody. In some experiments, blocking antibodies to IL-10 or isotype rat IgG1 control were also used, and after 72 h of incubation, incorporation of radioactivity was measured by liquid scintillation counting in triplicate. As shown in Figure 7A, the suppressive activity of Treg cells was aborated when an anti-IL-10 antibody was used.
###end p 48
###begin p 49
###xml 64 68 64 68 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 0 73 0 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IL-10 neutralizing antibody reversed suppressive activities of T<sub>reg </sub>cells</bold>
###xml 75 79 75 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 82 83 82 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 86 87 86 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 91 92 91 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 96 98 96 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 105 106 105 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 109 111 109 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 115 116 115 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 120 122 120 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 202 203 202 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 207 209 207 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 360 361 360 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 498 500 496 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 512 514 510 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p </italic>
###xml 524 528 522 526 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 812 816 809 813 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 819 820 816 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 824 829 821 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 170 174 <span type="species:ncbi:10090">mice</span>
###xml 551 555 <span type="species:ncbi:10090">mice</span>
###xml 638 641 <span type="species:ncbi:10116">rat</span>
###xml 875 879 <span type="species:ncbi:10090">mice</span>
IL-10 neutralizing antibody reversed suppressive activities of Treg cells. (A) CD4+CD8-CD25+CD44+ and CD4+CD8- CD25+CD44- cells were sorted from splenocytes from C57BL/6 mice and cultured with naive CD4+CD25- T cells in the presence of anti-CD3/anti-CD28 for 72 h. In some cases, anti-IL-10 or isotype control Ab was added. Cell proliferation was measured by [3H]-thymidine incorporation. Data are presented as counts for min, and shown are the mean +/- S.D. from three independent experiments (** p < 0.01, *** p < 0.001). (B) Splenocytes from naive mice were treated with either the IL-10 neutralizing antibodies or an isotype control (rat IgG1) in the presence or absence of Con A (5 mug/ml) for 24 h. Cells were stained with antibodies against CD4, CD8, CD25, CD44, and Foxp3 and analyzed by flow cytometry. (C) CD4+CD25high cells were sorted from splenocytes of C57BL/6 mice and cultured with anti-IL-10 or isotype control Abs for 24 h. Cells were stained with antibodies against Foxp3 and CD4 and analyzed by flow cytometry. Data are presented as the percentage of total splenocytes and shown are representative results of one of four independent experiments.
###end p 49
###begin p 50
###xml 33 37 33 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 499 501 498 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 556 557 555 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 561 562 560 561 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 269 272 <span type="species:ncbi:10116">rat</span>
It is known that Foxp3 controls Treg cell development and function. To validate the contribution of IL-10 in regulating T cell development and function, we obtained splenocytes from naive mice and treated them with an IL-10 neutralizing antibody or an isotype control (rat IgG1) in the presence or absence of Con A (5 mug/ml) for 24 h, with GolgiPlug in the medium for the last 3 h. Cells were stained with antibodies against CD4, CD8, CD25, CD44, and Foxp3 and analyzed by FACS. As shown in Figure 7B, Foxp3 expression levels were much lower (1.4%) in CD4+CD25+cells treated with anti-IL-10 antibody than those treated with an isotype control (17.3%) or without antibody (28%).
###end p 50
###begin p 51
###xml 19 20 19 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 24 29 24 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C</xref>
###xml 293 294 293 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 298 300 298 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 479 483 479 483 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
Next, we sorted CD4+CD25high cells and incubated them alone or togather with IL-10 blocking antibody or isotype control. After 24 h of incubation, the cells were harvested and anayzed. As shown in Figure 7C, Foxp3 expression were signficnatly decreased by the addition of anti-IL-10 in the CD4+CD25+ population of the cells (8%) than those treated with an isotype control (19%) or without antibody (23%). These data suggested an invovlment of IL-10 in suppressive mechanisms of Treg cells.
###end p 51
###begin title 52
Discussion
###end title 52
###begin p 53
###xml 49 50 49 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 54 55 54 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 59 60 59 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 61 65 61 65 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 154 162 154 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 223 228 223 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 247 252 247 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 279 280 279 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 284 285 284 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 289 294 289 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 321 325 321 325 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 346 347 346 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 351 352 351 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 356 360 356 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 387 391 387 391 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 436 440 436 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">via </italic>
###xml 564 568 564 568 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 636 637 636 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 638 642 638 642 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 712 716 712 716 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 655 660 <span type="species:ncbi:10090">mouse</span>
In this study, we have provided evidnece that CD4+CD25+CD44+Treg cells expressed high levels of Foxp3, IL-10, and displayed a potent suppressive function in vitro. Our results are consistant with those reported by Bookimin et al. [26] and Bollyky et al. [27], suggesting that CD4+CD25+CD44high cells display more potent Treg functions than do CD4+CD25+CD44low cells. As expected, these Treg cells suppress effector T cell proliferation via the production of IL-10. The significance of this study is that it highlights the functional relevence of CD44 in defining Treg cell subsets and may explain the unique developmental pathway of CD4+Treg cells in the mouse thymus and the subtle differences between various Treg cell subsets.
###end p 53
###begin p 54
###xml 213 218 213 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 288 290 288 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 291 295 291 295 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 549 550 549 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 553 555 553 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 590 591 590 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 594 595 594 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 599 600 599 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 604 606 604 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 613 614 613 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 617 618 617 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 622 623 622 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 627 629 627 629 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 630 634 630 634 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 732 734 732 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 753 754 753 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 757 758 757 758 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 762 763 762 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 767 769 767 769 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 807 808 807 808 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 811 812 811 812 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 816 817 816 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 821 823 821 823 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 853 855 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 304 310 <span type="species:ncbi:9606">infant</span>
The use of better markers or marker combinations in multi-color flow cytometry has made it possible to resolve and define many very small populations of lymphoid progenitors and mature cells. For example, Seddiki et al. used 38 surface markers and revealed the persistence of naive CD45RA+ Treg cells in infant thymus, cord or adult peripheral blood, lymph nodes, and spleen [28]. In this study, the simultaneous use of mAbs specific for CD4, CD8, CD25 and CD44 allowed us to detect 16 subtypes of thymocytes, with 80% of the thymocytes as being CD4+CD8+ cells (data no shown). Of note, CD4+CD8-CD25+CD44+ and CD4+CD8-CD25+CD44- Treg cells in the thymus constituted only 0.4% and 0.8%, respectively, of the total thymocytes (Figure 1B). While 72% of CD4+CD8-CD25+CD44+ cells expressed Foxp3, only 28% of CD4+CD8-CD25+CD44- cells expressed Foxp3 (Figure 1C).
###end p 54
###begin p 55
###xml 74 76 71 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 77 79 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 216 217 213 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 221 223 218 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 224 228 221 225 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 245 246 242 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 247 249 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 299 303 293 297 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 353 357 344 348 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 453 454 444 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 457 458 448 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 462 463 453 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 467 469 458 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 523 524 511 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 527 528 515 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 532 533 520 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 537 539 525 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 553 555 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 571 576 559 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 577 581 565 569 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 652 656 637 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink">med </sup>
###xml 663 667 648 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink">low </sup>
###xml 693 698 678 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 699 703 684 688 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 818 822 797 801 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 865 867 844 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 967 971 943 947 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1025 1029 1001 1005 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 1059 1060 1035 1036 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1064 1066 1040 1042 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1093 1097 1069 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink">via </italic>
###xml 1148 1150 1124 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1357 1358 1333 1334 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1362 1364 1338 1340 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1435 1437 1405 1407 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 98 113 <span type="species:ncbi:10090">transgenic mice</span>
The TCR-beta locus plays an important role in the development of T cells [23,24]. Although in TCR transgenic mice, exposure of the developing T cells to the cognate peptide in the thymus causes an increase in the CD4+CD25+ Treg cell population [3,29], it is unclear how the TCRbeta-chain regulates Treg cells. We examined TCR-beta expression in thymic Treg cell development. Cells in these transition stages begin to express TCR genes. We found that CD4+CD8-CD25+CD44+ cells expressed higher levels of TCR-beta than did CD4+CD8-CD25+CD44- cells (Figure 2B), and that CD44high Treg cells from the thymus displayed higher levels of TCR-beta than did CD44med or CD44low cells. Almost 100% of CD44high Treg cells expressed the TCR-beta-chain, whereas the frequency of TCR-beta-expressing cells was significantly lower in Treg cells with reduced CD44 expression (Figure 2C). Thus, our data suggest that the levels of TCR-beta expression indicate the maturation status of Treg cells and correlate with the suppressive function of Treg cells. It is possible that CD4+CD25+ T cells require activation via their TCR to differentiate into suppressive cells [30]. Here, it should be mentioned that at the CD4 SP stage, thymocytes have already passed positive selection by virtue of TCR mediated signaling events. Nevertheless, our data implies that ~60% of CD4 SP CD25+CD44- cells do not express a TCR-beta chain. It is not clear whether TCR-beta- cells might reflect a "spillover" from the double negative (DN) compartment and this possibility will be examined in the future.
###end p 55
###begin p 56
###xml 124 125 124 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 129 131 129 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 132 136 132 136 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 377 378 377 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 390 391 390 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 394 395 394 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 399 401 399 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 410 411 410 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 414 415 414 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 419 424 419 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
It is known that Foxp3 is a conserved transcription factor that programs the development and the suppressive function of CD4+CD25+ Treg cells. However, less is known about the Foxp3 expression pattern during thymocyte development. To address this issue, we examined the inter-relationship among the expression profiles of CD25, Foxp3, and CD44 and found several trends (Figure 3). Since CD4+CD8-CD44+ SP or CD4+CD8-CD44high SP cells expressed high levels of Foxp3, our data suggest a positive correlation between Foxp3 expression and expression of CD44 and the TCR-beta-chain. Additional precursor progeny studies are needed to further test/validate this hypothesis.
###end p 56
###begin p 57
###xml 65 69 65 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 217 226 217 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 340 341 340 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 344 345 344 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 349 350 349 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 354 356 354 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 373 374 373 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 377 378 377 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 382 383 382 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 387 389 387 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 403 404 403 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 418 419 418 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 422 423 422 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 427 428 427 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 432 437 432 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 531 533 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5E</xref>
###xml 631 635 631 635 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 709 711 709 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 759 763 759 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">via </italic>
###xml 857 861 857 861 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 898 899 898 899 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 903 904 903 904 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 908 910 908 910 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 915 916 915 916 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 986 987 986 987 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 991 992 991 992 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 996 998 996 998 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1003 1005 1003 1005 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1019 1020 1019 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 1112 1114 1112 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 1175 1177 1175 1177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 1182 1184 1182 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C</xref>
###xml 1432 1434 1432 1434 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1500 1504 1500 1504 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 211 215 <span type="species:ncbi:10090">mice</span>
Because functional assays are critical parameters for assessing Treg cell function, we used CD4, CD8, CD25, and CD44 markers and the FACSAria sorter to carefully isolate T cell subsets from the spleens of naive mice. In vitro T cell co-culture and RT-PCR assays indicated stronger suppressive function and higher mRNA levels of IL-10 in CD4+CD8-CD25+CD44+ cells than in CD4+CD8-CD25+CD44- cells (Figure 5). Because CD4+CD8-CD25+CD44high cells displayed the highest suppressive function and the highest mRNA levels of IL-10 (Figure 5E), we suggest that CD44 can be considered a complementary marker for the functional potential of Treg cells. To further support this conclusion, we isolated four subsets of CD4+ thymocytes and examined their IL-10 mRNA levels via real-time RT-PCR analysis. We provided two lines of evidence indicating the role of IL-10 in Treg cell-mediated suppression. First, CD4+CD25+CD44+ Foxp3+cells expressed much higher levels of intracellular IL-10 than did CD4+CD25+CD44- Foxp3+ cells (Figure 6). Second, the addition of an IL-10 neutralizing antibody reversed this suppression (Figure 7A), and affected Foxp3 expression in the splenocytes (Figures 7B and 7C). Whether, IL-10 neutralizing antibody reversed this suppression through regulating Foxp3 expression is currently not known and will be explored in the future. One possibility exists that our cell population might contain IL-10 producing non-Foxp3+ T cells, so called Tr1-like cells, that could cause reduction in Treg cell suppressive effect using anti-IL-10 antibodies; however, this possibility seemed highly unlikely but will be examined in our future studies.
###end p 57
###begin p 58
###xml 118 119 118 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 122 123 122 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 127 128 127 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 132 134 132 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 145 146 145 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 149 150 149 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 154 155 154 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 159 161 159 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 172 173 172 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 176 177 176 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 181 182 181 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 186 188 186 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 233 235 233 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 290 294 290 294 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 443 447 443 447 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
Our results suggest that the regulatory/suppressive potential of these cells can be ranked in the following order: CD4+CD8-CD25+CD44+ cells > CD4+CD8-CD25+CD44- cells > CD4+CD8-CD25-CD44+ cells. Thus, one would predict that naive CD4+ T cells may have a higher possibility to convert into Treg cells in the periphery than do their counterparts. Additional experiments are warranted to test this possibility, because a better understanding of Treg cell conversion and acquisition has potential therapeutic utility for autoimmunity and transplantation.
###end p 58
###begin p 59
###xml 46 50 46 50 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 85 86 85 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 90 91 90 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 95 97 95 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 104 105 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 109 110 109 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 114 116 114 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 157 158 157 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 162 163 162 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 167 172 167 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 199 203 199 203 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 346 350 346 350 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
In summary, we found two novel phenotypes of Treg cells in the thymus. While both CD4+CD25+CD44+ and CD4+CD25+CD44- cells display suppressive activities, CD4+CD25+CD44high cells are the most potent Treg cells. The expression levels of CD44 positively correlate with the expression of IL-10 and Foxp3, as well as with the regulatory potential of Treg cells which suppresses T cell proliferation function by producing IL-10.
###end p 59
###begin title 60
Competing interests
###end title 60
###begin p 61
The authors declare that they have no competing interests.
###end p 61
###begin title 62
Authors' contributions
###end title 62
###begin p 63
TL and LS contributed equally to the design of the study and writing of the manuscript; TL performed the experiments and analyzed data; GL and RK participated in experimental design, data analysis, and manuscript preparation; AKC provided support for this research, contributed in designing the study and manuscript writing and revisions, as well as in responding to reviewers' comments. All authors substantially contributed to the redaction of the manuscript and have given final approval on the version to be published.
###end p 63
###begin title 64
Reviewer's Comments
###end title 64
###begin title 65
Reviewers' report 1
###end title 65
###begin p 66
Dr. Lenardo
###end p 66
###begin p 67
###xml 107 108 107 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 112 113 112 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 117 119 117 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 141 146 <span type="species:ncbi:10090">mouse</span>
Liu et al., demonstrate CD44 as a new marker for Tregs in their manuscript entitled "The development of CD4+CD25+CD44+ regulatory T cells in mouse thymus". The authors have clearly shown that Foxp3 expression and enhanced suppressive activity of Tregs are associated with CD44 molecule. The authors have presented a concise report of their findings in a well-written manuscript and clearly presented data. They have also speculated that Tregs may develop from DN2 or DN3 stage T cells separately before development of naive cells.
###end p 67
###begin p 68
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Authors' response</italic>
###xml 19 304 19 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">We were very pleased to read your supporting comments on our study and felt that your suggestions were very helpful in assisting us to improve the quality of the revised manuscript. Based upon your suggestions, we have performed new experiments and presented these data in new Figures </italic>
###xml 304 305 304 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 305 309 305 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">and </italic>
###xml 309 310 309 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 312 380 312 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In addition, we have addressed your specific comments point-by-point</italic>
Authors' response: We were very pleased to read your supporting comments on our study and felt that your suggestions were very helpful in assisting us to improve the quality of the revised manuscript. Based upon your suggestions, we have performed new experiments and presented these data in new Figures 6and 7. In addition, we have addressed your specific comments point-by-point.
###end p 68
###begin p 69
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1) </bold>
###xml 239 241 239 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
1) The authors have not shown any evidence with regards to the Treg development other than CD25 and CD44 staining. Therefore, the title is misleading and changes the focus of the actual content of the paper i.e., CD44 correlates with Foxp3+ expression. There is no scientific evidence presented in the paper, showing that Treg cells actually arise from DN3 or 2/DN3 cell stage cells. The possibility that Treg cells could develop from DN4 cell stage cells by reacquiring CD44 and CD25 during negative selection and maturation processes has not been formally excluded. There is a school of thought that Treg cells escape negative selection even-though they have high affinity self-ligands. The authors should therefore address these points if they want to discuss about developmental aspects of Tregs in this paper. Otherwise, the authors should change the title of the manuscript and speculate the developmental aspects of Tregs only in the "discussion" section.
###end p 69
###begin p 70
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Authors' response</italic>
###xml 19 163 19 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">To address question 1, we have changed the title to "CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4</italic>
###xml 163 164 163 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 164 165 164 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 165 169 165 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">reg </italic>
###xml 165 169 165 169 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>reg </italic></sub>
###xml 169 337 169 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells", as suggested by the reviewer. We have also removed the original Figure Seven from the revised manuscript and provided a brief discussion on the development of T</italic>
###xml 337 341 337 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">reg </italic>
###xml 337 341 337 341 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>reg </italic></sub>
###xml 341 390 341 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells in the revised discussion of the manuscript</italic>
Authors' response: To address question 1, we have changed the title to "CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+Treg cells", as suggested by the reviewer. We have also removed the original Figure Seven from the revised manuscript and provided a brief discussion on the development of Treg cells in the revised discussion of the manuscript.
###end p 70
###begin p 71
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">2) </bold>
###xml 175 184 169 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 507 509 501 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 584 586 578 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 601 603 595 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 617 619 611 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
2) It is interesting that CD44 expression is coupled to the TGF-beta and IL-10 expression. However, it has been shown previously that TGF-beta and IL-10 are not necessary for in vitro suppression. Therefore, if authors claim CD44 expression positively correlates with higher suppression and these suppressive cytokines, the authors should demonstrate if CD44 high subset of Tregs suppress predominantly by these suppressive cytokines. It would be interesting to test whether the suppressive activity of CD44+ subset is blocked by neutralizing these cytokines. It is possible that CD44- subset and CD44+ subset of CD25+ Tregs suppress in different manner, which is why one cannot abrogate suppression by neutralizing TGF-beta and IL-10 in cultures with both the subsets so far.
###end p 71
###begin p 72
###xml 0 96 0 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Authors' response: To address question 2, our new data showed that suppressive function of CD4 T</italic>
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">reg </italic>
###xml 96 100 96 100 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>reg </italic></sub>
###xml 100 194 100 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells on T cell proliferation could be reversed by neutralizing anti-IL-10 antibodies (Figure </italic>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 199 334 199 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Further, our data provided evidence that IL-10 might regulate suppression of T cell proliferation function by modulating Foxp3 (Figure </italic>
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
Authors' response: To address question 2, our new data showed that suppressive function of CD4 Treg cells on T cell proliferation could be reversed by neutralizing anti-IL-10 antibodies (Figure 7A). Further, our data provided evidence that IL-10 might regulate suppression of T cell proliferation function by modulating Foxp3 (Figure 7B).
###end p 72
###begin title 73
Reviewers' report 2
###end title 73
###begin p 74
Dr Klein & Dr Wirnsberger (nominated by Dr JC Zungia-Pfluker)
###end p 74
###begin p 75
###xml 107 109 107 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
The manuscript "CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells" by Liu et al. proposes a subdivision of thymic and splenic Treg into populations characterized by different levels of CD44 expression. Although the revised ms deals with the functional properties of these subpopulations rather than focusing on developmental aspects of Treg cell biology, several major concerns remain as to the characterization of these cells and the interpretation of the reported experiments. Because the focus of the ms has profoundly changed, we have looked at it as if it were a first submission.
###end p 75
###begin p 76
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1) </bold>
###xml 17 98 17 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">"...the surface expression of CD44 in mouse thymocytes preceded that of Foxp3" - </italic>
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
1) Introduction: "...the surface expression of CD44 in mouse thymocytes preceded that of Foxp3" - this statement implies a direct precursor/progeny relationship between the described subpopulations and "mature" Treg that is not experimentally addressed at all in this manuscript.
###end p 76
###begin p 77
###xml 0 185 0 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Authors' response: Since our data indicated that CD44 expression positively correlated with Foxp3 expression, we have revised this line in the introduction to correctly reflect our data</italic>
Authors' response: Since our data indicated that CD44 expression positively correlated with Foxp3 expression, we have revised this line in the introduction to correctly reflect our data.
###end p 77
###begin p 78
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">2) </bold>
###xml 10 11 10 11 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 40 99 40 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">location and sequence of Treg development remain unclear." </italic>
2) Figure 1: The authors claim that "...location and sequence of Treg development remain unclear." Significant progress has been made in terms of a delineation of critical events during the earliest phase(s) of Treg differentiation and also in terms of the localization of their differentiation, which are not referenced here (Lio et al., 2008, Lee et al., 2009, Fontenot et al., 2005).
###end p 78
###begin p 79
###xml 261 278 261 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">thymic Treg cells</italic>
###xml 412 414 412 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
The following characterization of thymocyte subpopulations is based upon CD4/8/25/44 staining. Although the authors avoid calling these populations Treg at that point, the subsequent experiments are done using this staining scheme and cells are referred to as "thymic Treg cells" later on. The only specific Treg marker to date is Foxp3, hence - especially given the already reported heterogeneity of CD4 SP CD25+ cells - Foxp3 staining would be essential for these types of analyses.
###end p 79
###begin p 80
###xml 0 268 0 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Authors' response: As suggested by the reviewer, we have added the following references: Lio et al., 2008, Lee et al., 2009, Fontenot et al., 2005 in the revised manuscript. In addition, we have performed new experiments and added data showing "Foxp3 expression in CD4</italic>
###xml 268 269 268 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 269 272 269 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD8</italic>
###xml 272 273 272 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 273 277 273 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD25</italic>
###xml 277 278 277 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 278 282 278 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD44</italic>
###xml 282 283 282 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 283 290 283 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">and CD4</italic>
###xml 290 291 290 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 291 294 291 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD8</italic>
###xml 294 295 294 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 295 299 295 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD25</italic>
###xml 299 300 299 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 300 304 300 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD44</italic>
###xml 304 305 304 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 305 327 305 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells (see new Figure </italic>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
Authors' response: As suggested by the reviewer, we have added the following references: Lio et al., 2008, Lee et al., 2009, Fontenot et al., 2005 in the revised manuscript. In addition, we have performed new experiments and added data showing "Foxp3 expression in CD4+CD8-CD25+CD44+and CD4+CD8-CD25+CD44-cells (see new Figure 1C).
###end p 80
###begin p 81
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">3) </bold>
###xml 10 11 10 11 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 277 278 277 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 311 312 311 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 316 318 316 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
3) Figure 2: At the CD4 SP stage, thymocytes have already passed positive selection by virtue of TCR mediated signaling events. Additionally, as stated in the introduction, Treg differentiation is thought to rely on thymic antigen encounter/TCR signaling. Nevertheless, Figure 2 implies that ~60% of CD4 SP CD25+CD44- ("Treg") cells do not express a TCR-beta chain. This discrepancy is not discussed in the manuscript at all and might reflect a "spillover" from the DN compartment.
###end p 81
###begin p 82
###xml 0 71 0 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Authors' response: We agree with the reviewer that our original Figure </italic>
###xml 71 72 71 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 72 148 72 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">was not very clear and that it may cause some confusion. The revised Figure </italic>
###xml 148 149 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 149 198 149 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">now only focuses on TCR-&#946; expression among CD4</italic>
###xml 198 199 195 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 199 203 196 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD25</italic>
###xml 203 204 200 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 204 208 201 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD44</italic>
###xml 208 209 205 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 209 216 206 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">and CD4</italic>
###xml 216 217 213 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 217 221 214 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD25</italic>
###xml 221 222 218 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 222 226 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD44</italic>
###xml 226 227 223 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 227 322 224 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SP cells. We have expanded the discussion section and included reviewer's point in this section</italic>
Authors' response: We agree with the reviewer that our original Figure 2was not very clear and that it may cause some confusion. The revised Figure 2now only focuses on TCR-beta expression among CD4+CD25+CD44-and CD4+CD25+CD44+SP cells. We have expanded the discussion section and included reviewer's point in this section.
###end p 82
###begin p 83
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">4) </bold>
###xml 10 11 10 11 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 84 86 81 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 301 308 292 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">"...CD4</italic>
###xml 308 309 299 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 309 313 300 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD25</italic>
###xml 313 314 304 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 314 318 305 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD44</italic>
###xml 318 319 309 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 319 374 310 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells represent a more mature subset of Treg cells..." </italic>
4) Figure 3: The authors also claim to detect both different percentages of TCR-beta+ cells and different levels of TCR-beta expression among the described populations. Staining showing different levels of TCR-beta expression among the described subsets are not provided, however. The suggestion that "...CD4+CD25+CD44+cells represent a more mature subset of Treg cells..." based upon the presented staining (lacking Foxp3 staining) and lacking any experiments providing evidence for a precursor/progeny relationship is daring.
###end p 83
###begin p 84
###xml 0 59 0 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Authors' response: We think that the reviewer meant Figure </italic>
###xml 59 60 59 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 60 75 60 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">and not Figure </italic>
###xml 75 76 75 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 78 95 78 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">We found that CD4</italic>
###xml 95 96 95 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD25</italic>
###xml 100 101 100 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 101 105 101 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD44</italic>
###xml 105 106 105 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 106 186 106 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells expressed the highest level TCR-&#946; in thymocytes. So we believe that CD4</italic>
###xml 186 187 183 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 187 191 184 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD25</italic>
###xml 191 192 188 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 192 196 189 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD44</italic>
###xml 196 197 193 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 197 271 194 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells were more mature T cells. We meant mature T cells and not Treg cells</italic>
Authors' response: We think that the reviewer meant Figure 2and not Figure 3. We found that CD4+CD25+CD44+cells expressed the highest level TCR-beta in thymocytes. So we believe that CD4+CD25+CD44+cells were more mature T cells. We meant mature T cells and not Treg cells.
###end p 84
###begin p 85
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">5) </bold>
###xml 18 19 18 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 51 53 51 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 119 120 119 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 124 125 124 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 129 131 129 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 179 180 179 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 277 278 277 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 283 284 283 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 358 359 358 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 382 383 382 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 437 439 437 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
5) Data in Figure 3 show that essentially all Foxp3+ cells are also CD44+/high, but that only a "small" fraction of CD4+CD25+CD44+ cells - as classified by the authors - are Foxp3+. These results clearly necessitate a re-examination of the results and interpretation of Figure 1 and 2. The results presented also argue for a relatively low percentage of CD25+/high cells being Foxp3+, which is not consistent with the literature on Foxp3+ cells in the (adult) thymus (Fontenot et al., 2005).
###end p 85
###begin p 86
###xml 0 187 0 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Authors' response: We appreciate for reviewer's insightful comments. In more than 10 independent repeats, we sometimes detected higher frequencies and sometimes lower frequencies of Foxp3</italic>
###xml 187 188 187 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 188 370 188 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells. To confirm the trends, we carefully performed additional experiments. After careful reviewing all of our data, especially the new data, we decided to present a revised Figure </italic>
###xml 370 371 370 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 373 581 373 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">showing our new data. This is not to say that the old data were wrong, since it is a cellular staining, Foxp3 expression varied in different samples. Importantly, however, the rate of Foxp3 expression in CD44</italic>
###xml 581 582 581 582 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 582 590 582 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">and CD44</italic>
###xml 590 591 590 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 591 637 591 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">subset was similar in all of the data analyzed</italic>
Authors' response: We appreciate for reviewer's insightful comments. In more than 10 independent repeats, we sometimes detected higher frequencies and sometimes lower frequencies of Foxp3+cells. To confirm the trends, we carefully performed additional experiments. After careful reviewing all of our data, especially the new data, we decided to present a revised Figure 3, showing our new data. This is not to say that the old data were wrong, since it is a cellular staining, Foxp3 expression varied in different samples. Importantly, however, the rate of Foxp3 expression in CD44+and CD44-subset was similar in all of the data analyzed.
###end p 86
###begin p 87
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6) </bold>
###xml 10 11 10 11 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 46 119 46 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">"functional assessment of Treg cell subsets in mouse thymus and spleen." </italic>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 93 98 <span type="species:ncbi:10090">mouse</span>
6) Figure 4: The authors claim to have done a "functional assessment of Treg cell subsets in mouse thymus and spleen." The data presented only show the suppressive activity of splenocytes. (For thymocytes: only Real Time PCR data are provided). The differences in suppressive potency (Figure 4A) are very modest. Additionally the authors show, that the described populations differ in their TGF-beta and IL-10 mRNA expression levels. The differences are modest and probably not too informative, however.
###end p 87
###begin p 88
###xml 0 518 0 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Authors' response: The only ways to show "functional assessment of Treg cell subsets in mouse thymus and spleen" are by RT-PCR, real Time RT-PCR and intercellular staining, and we obtained similar results with these different assays. Our experiments were limited by cell sorting conditions, as we could not sort enough of CD44 Treg cells, which influenced our results. However, we have provided new data in which Treg: effector cells were used in a ratio of 1:2, and the suppressive potency was impressive (new Figure </italic>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 88 93 <span type="species:ncbi:10090">mouse</span>
Authors' response: The only ways to show "functional assessment of Treg cell subsets in mouse thymus and spleen" are by RT-PCR, real Time RT-PCR and intercellular staining, and we obtained similar results with these different assays. Our experiments were limited by cell sorting conditions, as we could not sort enough of CD44 Treg cells, which influenced our results. However, we have provided new data in which Treg: effector cells were used in a ratio of 1:2, and the suppressive potency was impressive (new Figure 5A).
###end p 88
###begin p 89
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">7) </bold>
###xml 11 12 11 12 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 17 18 17 18 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 75 76 75 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 100 101 100 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
7) Figures 4 and 5 are redundant. It might not be necessary to show Figure 4 at all. RT PCR (Figure 5) and Real-time data (Figure 6A) are redundant. Assessing cytokine mRNA expression levels does not allow any statements on the suppressive potential of thymocyte populations (6B).
###end p 89
###begin p 90
###xml 0 54 0 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Authors' response: We agree that the original Figures </italic>
###xml 54 55 54 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">and </italic>
###xml 59 60 59 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 60 98 60 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">are redundant and have deleted Figure </italic>
###xml 98 99 98 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 101 121 101 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">We feel that Figure </italic>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 123 237 123 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">can help readers understand cytokine expression of Treg cells in the thymus, and have decided to have new Figures </italic>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5E</xref>
###xml 239 243 239 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">and </italic>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5F</xref>
Authors' response: We agree that the original Figures 4and 5are redundant and have deleted Figure 5. We feel that Figure 6Bcan help readers understand cytokine expression of Treg cells in the thymus, and have decided to have new Figures 5Eand 5F.
###end p 90
###begin p 91
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">8) </bold>
###xml 10 11 10 11 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 36 125 36 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">"CD44 Treg cells produce IL-10 and TGF-beta cytokines that suppress T cell proliferation"</italic>
###xml 237 246 237 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
8) Figure 7: The authors claim that "CD44 Treg cells produce IL-10 and TGF-beta cytokines that suppress T cell proliferation". The expression of TGF-beta by the described populations is not shown, however. Data on a role for TGF-beta in in vitro suppression assays is also not provided.
###end p 91
###begin p 92
###xml 0 71 0 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Authors' response: We could not detect TGF-beta expression in both CD44</italic>
###xml 71 72 71 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 72 80 72 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">and CD44</italic>
###xml 80 82 80 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 82 245 82 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells with flow cytometry assay and the TGF-beta mRNA data were modest. We decided to delete TGF-beta data and to focus on IL-10 in Treg cells in later experiments</italic>
Authors' response: We could not detect TGF-beta expression in both CD44+and CD44- cells with flow cytometry assay and the TGF-beta mRNA data were modest. We decided to delete TGF-beta data and to focus on IL-10 in Treg cells in later experiments.
###end p 92
###begin p 93
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">9) </bold>
###xml 281 283 281 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 372 374 372 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 453 455 453 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
9) Figure 8B: involvement of IL-10 in direct regulation of Foxp3 expression seems to be problematic. Studies on a role of IL-10 and TGF-beta in Treg cell induction/homeostasis and suppressor function (Li and Flavell 2008, amongst many others) and a possible role for CD44 and Foxp3+ cells can - via intracellular staining - be visualized as a distinct population among CD4+ cells. The CD4/Foxp3 plots in Figure 8B do not really allow for gating on Foxp3+ cells. Due to the experimental setup and the lack of "resolution" provided by the Foxp3 staining shown an interpretation suggesting an low/high molecular weight hyaluronic-acid in Treg function (Bollyky et al., 2007) have been reported elsewhere and are not sufficiently referenced in this section.
###end p 93
###begin p 94
In aggregate, this manuscript provides some insights into how Treg can be subdivided into subpopulations differing in their suppressive potency based upon the expression of the hyaluronic-acid receptor CD44. However, the concerns mentioned above should be addressed in order to clarify the validity of the given interpretations and conclusions. We hope that these comments are helpful to improve the quality of this manuscript.
###end p 94
###begin p 95
###xml 0 192 0 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Authors' response: In this study, we have used anti-IL-10 antibody to block IL-10 in splenocytes, and we found that IL-10 induced Foxp3 expression was decreased. Furthermore, we sorted CD4CD25</italic>
###xml 192 196 192 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 196 347 196 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells from spleen of C57BL/6 mice, cultured themwith anti-IL-10 or rat IgG1 antibody for 24 hours, and analyzed data by Flow cytometry (revised Figure </italic>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C</xref>
###xml 352 416 352 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">We found IL-10 induced Foxp3 expression was decreased in CD4CD25</italic>
###xml 416 420 416 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 420 656 420 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells after blocking this cytokine with IL-10 neutralizing antibody. These results suggest that Treg cell suppressive effect on T cell proliferation could be reversed by IL-10 blocking antibody through regulation of the Foxp3 expression</italic>
###xml 225 229 <span type="species:ncbi:10090">mice</span>
###xml 263 266 <span type="species:ncbi:10116">rat</span>
Authors' response: In this study, we have used anti-IL-10 antibody to block IL-10 in splenocytes, and we found that IL-10 induced Foxp3 expression was decreased. Furthermore, we sorted CD4CD25highcells from spleen of C57BL/6 mice, cultured themwith anti-IL-10 or rat IgG1 antibody for 24 hours, and analyzed data by Flow cytometry (revised Figure 7C). We found IL-10 induced Foxp3 expression was decreased in CD4CD25highcells after blocking this cytokine with IL-10 neutralizing antibody. These results suggest that Treg cell suppressive effect on T cell proliferation could be reversed by IL-10 blocking antibody through regulation of the Foxp3 expression.
###end p 95
###begin p 96
Finally, we have added Li, Ming O and Richard A Flavell 2008 reference and that of Bollyky et al. 2007 in the revised manuscript
###end p 96
###begin title 97
Reviewers' report 3
###end title 97
###begin p 98
Dr Shevach
###end p 98
###begin p 99
The authors have changed the title of the paper and this does improve the focus of the manuscript. However, numerous issues remain to be resolved with this manuscript:
###end p 99
###begin p 100
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">1) </bold>
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 111 112 111 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 114 115 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 187 189 187 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 316 321 316 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high </sup>
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
1) The authors now accept that Foxp3 is the marker for Treg in the mouse, yet the data presented in figures 1, 2, 3 add absolutely nothing to our understanding of the development of Foxp3+ T cells in the thymus. Although they appear to perform competent staining, the level of Foxp3 expressing cells even in the CD44high pool is only 20%. It is not clear what new information is conveyed in these figures.
###end p 100
###begin p 101
###xml 0 115 0 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Authors' response: Although much is known about T cell development in the thymus, there is limited information on T</italic>
###xml 115 119 115 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">reg </italic>
###xml 115 119 115 119 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>reg </italic></sub>
###xml 119 154 119 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cell markers in the thymus. Figure </italic>
###xml 154 155 154 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 155 163 155 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">showsCD4</italic>
###xml 163 164 163 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 164 167 164 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD8</italic>
###xml 167 168 167 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 168 172 168 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD25</italic>
###xml 172 173 172 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 173 177 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD44</italic>
###xml 177 178 177 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 178 185 178 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">and CD4</italic>
###xml 185 186 185 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 186 189 186 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD8</italic>
###xml 189 190 189 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 190 194 190 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD25</italic>
###xml 194 195 194 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 195 199 195 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD44</italic>
###xml 199 200 199 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 200 244 200 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells in thymus, and Foxp3 expression in CD4</italic>
###xml 244 245 244 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 245 248 245 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD8</italic>
###xml 248 249 248 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 249 253 249 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD25</italic>
###xml 253 254 253 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 254 258 254 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD44</italic>
###xml 258 259 258 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 259 266 259 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">and CD4</italic>
###xml 266 267 266 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 267 270 267 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD8</italic>
###xml 270 271 270 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 271 275 271 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD25</italic>
###xml 275 276 275 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 276 280 276 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD44</italic>
###xml 280 281 280 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 281 295 281 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells. Figure </italic>
###xml 295 296 295 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 296 427 296 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">shows that TCR-&#946; locus plays an important role in the development of T cells. We compared the expression of TCR-&#946; in both CD4</italic>
###xml 427 428 421 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 428 432 422 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD25</italic>
###xml 432 433 426 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 433 437 427 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD44</italic>
###xml 437 438 431 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 438 445 432 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">and CD4</italic>
###xml 445 446 439 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 446 450 440 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD25</italic>
###xml 450 451 444 445 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 451 455 445 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD44</italic>
###xml 455 457 449 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 457 482 451 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells, and found that CD4</italic>
###xml 482 483 476 477 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 483 487 477 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD25</italic>
###xml 487 488 481 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 488 492 482 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD44</italic>
###xml 492 493 486 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 493 536 487 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells are mature cells. Our data in Figure </italic>
###xml 536 537 530 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 537 635 531 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">show that Foxp3 is positively correlated with CD44. Based on our new data, we have revised Figure </italic>
###xml 635 636 629 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
Authors' response: Although much is known about T cell development in the thymus, there is limited information on Treg cell markers in the thymus. Figure 1showsCD4+CD8-CD25+CD44+and CD4+CD8-CD25+CD44-cells in thymus, and Foxp3 expression in CD4+CD8-CD25+CD44+and CD4+CD8-CD25+CD44-cells. Figure 2shows that TCR-beta locus plays an important role in the development of T cells. We compared the expression of TCR-beta in both CD4+CD25+CD44+and CD4+CD25+CD44- cells, and found that CD4+CD25+CD44+cells are mature cells. Our data in Figure 3show that Foxp3 is positively correlated with CD44. Based on our new data, we have revised Figure 3.
###end p 101
###begin p 102
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">2) </bold>
###xml 155 156 155 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 327 329 327 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 341 342 341 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 423 425 423 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 483 484 483 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
2) The authors need to quantitate by intracellular staining the percentage of Foxp3 expressing cells in each of their so-called Treg populations in figure 4. As pointed out in my previous review, the magnitude of suppression in this figure is not great (compared to other published studies) and the differences between the CD44+ and the CD44-populations could easily be accounted by minor differences in percentage of Foxp3+ T cells. The same criticism applies to the data in figure 5.
###end p 102
###begin p 103
###xml 0 130 0 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Authors' response: We have quantitated by intracellular staining, the percentage of Foxp3 expressing cells in splenocytes (Figure </italic>
###xml 130 131 130 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 134 239 134 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Our experiments were limited by cell sorting conditions, as we could not get sufficient numbers of CD44 T</italic>
###xml 239 243 239 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">reg </italic>
###xml 239 243 239 243 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>reg </italic></sub>
###xml 243 399 243 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells. However, we have provided new data in which Treg: effector cells were used in a ratio of 1:2, and the suppressive potency was impressive (new Figure </italic>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
Authors' response: We have quantitated by intracellular staining, the percentage of Foxp3 expressing cells in splenocytes (Figure 4). Our experiments were limited by cell sorting conditions, as we could not get sufficient numbers of CD44 Treg cells. However, we have provided new data in which Treg: effector cells were used in a ratio of 1:2, and the suppressive potency was impressive (new Figure 5A).
###end p 103
###begin p 104
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">3) </bold>
###xml 50 51 50 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
3) The authors rely heavily on PCR data in figure 6. As suppression requires TCR activation, they need to stimulate the populations to determine how much of these cytokines they are capable of producing. Elisa assays and intracellular staining are needed. MOST IMPORTANTLY, they need to do simultaneous staining for IL-10 and Foxp3. We agree that this it is difficult to analyze TGF-beta by IC staining.
###end p 104
###begin p 105
###xml 0 58 0 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Authors' response: We have performed this study in Figure </italic>
###xml 58 59 58 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 61 403 61 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">The most critical step for detection of intracellular accumulation of cytokines by intracellular staining is activation of a cell population to induce production of cytokines of interest. We used Con A as an activator to co-culture with GolgiPlug in the medium. There was no IL-10 expression in control cells which were not activated by Con A</italic>
Authors' response: We have performed this study in Figure 6. The most critical step for detection of intracellular accumulation of cytokines by intracellular staining is activation of a cell population to induce production of cytokines of interest. We used Con A as an activator to co-culture with GolgiPlug in the medium. There was no IL-10 expression in control cells which were not activated by Con A.
###end p 105
###begin p 106
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink">4</bold>
###xml 51 52 51 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 94 95 94 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
4) The same criticism holds for the data in figure 7. Are the cells that stain for IL-10 Foxp3+? CD44 and CD25 are surrogate markers that mean little.
###end p 106
###begin p 107
###xml 0 65 0 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Authors' response: Yes, we have added data on IL-10 levels in CD4</italic>
###xml 65 66 65 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 66 69 66 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD8</italic>
###xml 69 70 69 70 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD25</italic>
###xml 74 75 74 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD44</italic>
###xml 79 80 79 80 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Foxp3</italic>
###xml 85 86 85 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 86 93 86 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">and CD4</italic>
###xml 93 94 93 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 94 97 94 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD8</italic>
###xml 97 98 97 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD25</italic>
###xml 102 103 102 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 103 107 103 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD44</italic>
###xml 107 108 107 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 108 113 108 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Foxp3</italic>
###xml 113 114 113 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 114 143 114 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells in the revised Figures </italic>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 145 149 145 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">and </italic>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
Authors' response: Yes, we have added data on IL-10 levels in CD4+CD8-CD25+CD44+Foxp3+and CD4+CD8-CD25+CD44-Foxp3+cells in the revised Figures 6Band 6D.
###end p 107
###begin p 108
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">5) </bold>
###xml 571 573 571 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 937 939 937 939 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 258 263 <span type="species:ncbi:10090">mouse</span>
###xml 307 312 <span type="species:ncbi:10090">mouse</span>
5) The suppression data in figure 8 lacks an important control. The authors need to add the anti-IL-10 to the naive T cells alone. Anti-IL-10 will frequently increase the response of this population as well. In general, anti-CD28 reverses suppression in the mouse model and it is very difficult to suppress mouse T cell activation in the presence of anti-CD28 (the authors might review some of the papers published years ago which address this point). It is unclear why the authors see a reversal of suppression with anti-IL-10 as other groups using highly purified Foxp3+ T cells have not seen this. There seems to be no difference in the susceptibility of the high versus the low population to anti-IL-10 reversal, so one would assume that their data should not differ from the published data using Tregs that are not fractionated based on CD44 expression. One possibility is that the cell populations contain IL-10 producing non-Foxp3+ T cells, so called Tr1-like cells.
###end p 108
###begin p 109
###xml 0 153 0 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Authors' response: Anti-IL-10 with na&#239;ve T cell data have been added (only anti-CD3 and not anti-CD28 in the medium) as a control. We have sorted CD4CD25</italic>
###xml 153 157 153 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 157 298 157 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells from spleen of C57BL/6 mice and cultured them with anti-IL-10 or Rat IgG1 for 24 hours, and analyzed by Flow cytometry (revised Figure </italic>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C</xref>
###xml 303 416 303 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Our data clearly and very reproducibly indicated that anti-IL-10 antibodies reversed the suppressive ability of T</italic>
###xml 416 420 416 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">reg </italic>
###xml 416 420 416 420 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>reg </italic></sub>
###xml 420 520 420 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells. Therefore, we are convinced that our data is accurate. However, it is possible that the Foxp3</italic>
###xml 520 521 520 521 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 521 599 521 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells isolated from transgenic mice might behave differently compared to Foxp3</italic>
###xml 599 601 599 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 601 770 601 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells from normal mice. The reviewer brought up an interesting point regarding Tr1-like cells. We have added this statement in the revised manuscript to cover all points</italic>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
###xml 228 231 <span type="species:ncbi:10116">Rat</span>
###xml 541 556 <span type="species:ncbi:10090">transgenic mice</span>
###xml 619 623 <span type="species:ncbi:10090">mice</span>
Authors' response: Anti-IL-10 with naive T cell data have been added (only anti-CD3 and not anti-CD28 in the medium) as a control. We have sorted CD4CD25highcells from spleen of C57BL/6 mice and cultured them with anti-IL-10 or Rat IgG1 for 24 hours, and analyzed by Flow cytometry (revised Figure 7C). Our data clearly and very reproducibly indicated that anti-IL-10 antibodies reversed the suppressive ability of Treg cells. Therefore, we are convinced that our data is accurate. However, it is possible that the Foxp3+cells isolated from transgenic mice might behave differently compared to Foxp3+ cells from normal mice. The reviewer brought up an interesting point regarding Tr1-like cells. We have added this statement in the revised manuscript to cover all points.
###end p 109
###begin p 110
###xml 0 3 0 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink">6) </bold>
###xml 227 229 227 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 370 372 370 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
6) a) Panel B of figure 8 is simply fantasy. I see no physiologic relevance to studying an unseparated population of thymocytes and splenocytes. b) Why do the authors add Con A? IL-10 deficient mice have normal numbers of Foxp3+ T cells. c) Why is there a difference between the medium control and the control IgG? d) This study needs to be performed with purified Foxp3+ cells from thymus and spleen. Considerable cell death occurs when thymocytes are cultured under these conditions, yet cell survival is not mentioned.
###end p 110
###begin p 111
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Authors' response</italic>
###xml 19 22 19 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a) </italic>
###xml 17 22 17 22 <bold xmlns:xlink="http://www.w3.org/1999/xlink">: <italic>a) </italic></bold>
###xml 22 182 22 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In this study, we have used anti-IL-10 to block IL-10 in splenocytes and found that IL-10 induced Foxp3 expression was decreased. Furthermore, we sorted CD4CD25</italic>
###xml 182 186 182 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 186 335 186 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells from spleen of C57BL/6 mice and cultured them with anti-IL-10 or Rat IgG1 for 24 hours, and analyzed samples by Flow cytometry (revised Figure </italic>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C</xref>
###xml 340 404 340 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">We found IL-10 induced Foxp3 expression was decreased in CD4CD25</italic>
###xml 404 408 404 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink">high</sup>
###xml 408 413 408 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells</italic>
###xml 415 418 415 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">b) </italic>
###xml 415 418 415 418 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>b) </italic></bold>
###xml 418 439 418 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In panel B of Figure </italic>
###xml 439 440 439 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 442 770 442 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">our data showed different level of Foxp3 expression between anti-IL-10 treated-versus control-cells and medium alone. However, more significant difference in Foxp3 expression between anti-IL-10 treated- and control-cells in the presence of ConA was noted. ConA may increase activity of T cells to influence Foxp3 expression on T</italic>
###xml 770 774 770 774 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reg </sub>
###xml 774 828 774 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cells. However, we did not use ConA in our new Figure </italic>
###xml 828 830 828 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C</xref>
###xml 832 835 832 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c) </italic>
###xml 832 835 832 835 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>c) </italic></bold>
###xml 835 952 835 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink">We believe that this antibody might not be highly purified; however, it did not influence the accuracy of our results</italic>
###xml 954 957 954 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d) </italic>
###xml 954 957 954 957 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>d) </italic></bold>
###xml 957 1043 957 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spleen samples but not thymus were used and the cells did not die in these experiments</italic>
###xml 215 219 <span type="species:ncbi:10090">mice</span>
###xml 257 260 <span type="species:ncbi:10116">Rat</span>
Authors' response: a) In this study, we have used anti-IL-10 to block IL-10 in splenocytes and found that IL-10 induced Foxp3 expression was decreased. Furthermore, we sorted CD4CD25highcells from spleen of C57BL/6 mice and cultured them with anti-IL-10 or Rat IgG1 for 24 hours, and analyzed samples by Flow cytometry (revised Figure 7C). We found IL-10 induced Foxp3 expression was decreased in CD4CD25highcells. b) In panel B of Figure 7, our data showed different level of Foxp3 expression between anti-IL-10 treated-versus control-cells and medium alone. However, more significant difference in Foxp3 expression between anti-IL-10 treated- and control-cells in the presence of ConA was noted. ConA may increase activity of T cells to influence Foxp3 expression on Treg cells. However, we did not use ConA in our new Figure 7C. c) We believe that this antibody might not be highly purified; however, it did not influence the accuracy of our results. d) Spleen samples but not thymus were used and the cells did not die in these experiments.
###end p 111
###begin title 112
Acknowledgements
###end title 112
###begin p 113
We thank Mardelle Susman for assisting in manuscript preparation. This study was supported in part by NIH grants AI064389 and N01-30065 (to A.K. Chopra) and NIH grant AI043003 (to L. Soong).
###end p 113
###begin article-title 114
###xml 10 11 10 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 15 17 15 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
How do CD4+CD25+ regulatory T cells control autoimmunity?
###end article-title 114
###begin article-title 115
###xml 50 51 50 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 55 57 55 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
###end article-title 115
###begin article-title 116
Origin of regulatory T cells with known specificity for antigen
###end article-title 116
###begin article-title 117
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 28 30 28 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide
###end article-title 117
###begin article-title 118
###xml 5 7 5 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 11 13 11 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Foxp3+ CD25+ regulatory T cells specific for a neo-self-antigen develop at the double-positive thymic stage
###end article-title 118
###begin article-title 119
Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression
###end article-title 119
###begin article-title 120
A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3
###end article-title 120
###begin article-title 121
Foxp3-dependent programme of regulatory T-cell differentiation
###end article-title 121
###begin article-title 122
Inducing and expanding regulatory T cell populations by foreign antigen
###end article-title 122
###begin article-title 123
Coexpression of TGF-beta1 and IL-10 enables regulatory T cells to completely suppress airway hyperreactivity
###end article-title 123
###begin article-title 124
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 8 10 8 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
CD4+CD25+ regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]
###end article-title 124
###begin article-title 125
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 28 30 28 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 52 54 52 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10
###end article-title 125
###begin article-title 126
Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10
###end article-title 126
###begin article-title 127
###xml 66 72 <span type="species:ncbi:9606">humans</span>
Interleukin-10-secreting type 1 regulatory T cells in rodents and humans
###end article-title 127
###begin article-title 128
###xml 25 27 25 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 30 32 30 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 36 38 36 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 61 63 61 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 67 69 67 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Characterization of Foxp3+ CD4+ CD25+ and IL-10-secreting CD4+ CD25+ T cells during cure of colitis
###end article-title 128
###begin article-title 129
Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces
###end article-title 129
###begin article-title 130
Hyaluronan anchoring and regulation on the surface of vascular endothelial cells is mediated through the functionally active form of CD44
###end article-title 130
###begin article-title 131
Requirement for CD44 in proliferation and homing of hematopoietic precursor cells
###end article-title 131
###begin article-title 132
A positive look at double-negative thymocytes
###end article-title 132
###begin article-title 133
Developmental regulation of Foxp3 expression during ontogeny
###end article-title 133
###begin article-title 134
A two-step process for thymic regulatory T cell development
###end article-title 134
###begin article-title 135
Rare development of Foxp3+ thymocytes in the CD4+CD8+ subset
###end article-title 135
###begin article-title 136
T-cell development and the CD4-CD8 lineage decision
###end article-title 136
###begin article-title 137
CD4/CD8-lineage differentiation in the thymus: from nuclear effectors to membrane signals
###end article-title 137
###begin article-title 138
###xml 3 5 3 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 9 11 9 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
CD4+ CD25+ T regulatory cells and TGF-beta in mucosal immune system: the good and the bad
###end article-title 138
###begin article-title 139
Gut flora antigens are not important in the maintenance of regulatory T cell heterogeneity and homeostasis
###end article-title 139
###begin article-title 140
###xml 86 88 86 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 92 94 92 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+ CD25+ regulatory T cells
###end article-title 140
###begin article-title 141
###xml 27 29 27 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Persistence of naive CD45RA+ regulatory T cells in adult life
###end article-title 141
###begin article-title 142
###xml 17 19 17 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 23 25 23 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
Generation of CD4+ CD25+ regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression
###end article-title 142
###begin article-title 143
Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection
###end article-title 143

